On October 2, 2019, Adicet Bio, Inc. closed the transaction. The transaction included participation from 18 investors including new investors aMoon Fund., DSC Investment Inc. (KOSDAQ:A241520), Handok, Inc. (KOSE:A002390), Johnson & Johnson Innovation - JJDC, Inc., KB Investment Co., Ltd., OCI Enterprises, Inc., Regeneron Pharmaceuticals, Inc. (NasdaqGS:REGN), Samsung Venture Investment Corporation, SBI JI Innovation Advisory Ltd., and Vincos Limited, and existing investors including Novartis Venture Funds, OrbiMed Advisors, L.L.C., Pontifax Ltd. Representative from Johnson & Johnson Innovation - JJDC, Inc. and Yair Schindel from aMoon Fund will join company's board of directors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,295 KRW | -2.08% | -9.35% | +4.94% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
14,890 KRW | +2.06% | +0.95% | 144M | ||
1,069 USD | -0.19% | +2.37% | 116B | ||
1.34 USD | -8.84% | -1.47% | 121M | ||
1st Jan change | Capi. | |
---|---|---|
+4.94% | 64.81M | |
+20.88% | 3.2B | |
+12.50% | 1.76B | |
+12.27% | 1.59B | |
-11.54% | 1.22B | |
+34.73% | 906M | |
+6.98% | 650M | |
+54.70% | 603M | |
-4.17% | 504M | |
+20.19% | 435M |
- Stock Market
- Equities
- A241520 Stock
- News DSC Investment Inc.
- Adicet Bio, Inc. announced that it has received $80 million in funding from a group of investors